as a mixture before, after, and during inflammation by causing an effect on JAK/STAT and NF-kB signaling pathways to determine whether they could be used as therapeutic or preventive options for inflammatory conditions, including IBD. Here, SOAT1 is linked to inflammatory bowel disease.